People with Alzheimer's disease have been found to have reduced amyloid (Aβ1-42) and increased phosphorylated tau (p-tau181p) and total tau (t-tau) in the CSF [64]. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.